CFR: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	482,305	307,925
Credit loss expense	32,978	26,199
Deferred tax expense (benefit)	3,047	-4,017
Accretion of loan discounts	20,588	13,718
Securities premium amortization (discount accretion), net	-28,907	-20,128
Net (gain) loss on securities transactions	-14	-14
Depreciation and amortization	65,969	43,734
Net (gain) loss on sale/write-down of assets/foreclosed assets	2,294	2,374
Stock-based compensation	13,183	8,913
Net tax benefit from stock-based compensation	-1,816	-1,376
Earnings on life insurance policies	2,908	1,882
Trading account securities	2,336	4,309
Lease right-of-use assets	18,227	12,887
Accrued interest receivable and other assets	-69,262	-1,530
Accrued interest payable and other liabilities	-594,338	-551,745
Net cash from operating activities	93,244	-155,339
Securities held-to-maturity - purchases	1,500	1,500
Securities held to maturity maturities, calls and principal repayments	77,501	46,888
Purchases	15,386,824	8,285,846
Sales	41,207	38,556
Maturities, calls and principal repayments	13,903,659	6,882,720
Proceeds from sale of loans	14,119	7,305
Net change in loans	712,382	514,111
Net cash paid in insurance agency asset acquisition	0	-
Benefits received on life insurance policies	1,777	1,820
Proceeds from sales of premises and equipment	44	38
Purchases of premises and equipment	104,136	67,218
Proceeds from sales of foreclosed assets	15,135	15,135
Net cash from investing activities	-2,151,400	-1,876,213
Net change in deposits	-205,596	-1,039,134
Net change in short-term borrowings	230,608	79,163
Proceeds from stock option exercises	7,881	5,956
Purchase of treasury stock	72,461	2,676
Cash dividends paid on preferred stock	5,006	3,338
Cash dividends paid on common stock	191,292	126,590
Net cash from financing activities	-235,866	-1,086,619
Net change in cash and cash equivalents	-2,294,022	-3,118,171
Cash and cash equivalents at beginning of period	10,234,258	-
Cash and cash equivalents at end of period	7,940,236	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

CFR: the cashflow